Xenon Pharmaceuticals (XENE) Reports Q3 Loss of $0.43

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.43), versus ($0.51) reported last year.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Designer Brands (DBI) PT Lowered to $6 at UBS